CATEGORIES

INDIGENOUS MEDICAL DEVICE AND DIAGNOSTICS MARKET GROWING AT 6% CROSSES RS 36,000 CRORE

The market of indigenous medical device and diagnostics is estimated at Rs 36,400 crore growing at 6 per cent for 2018-19.

Government's Nano approach for pharma industry

Nanotechnology is now known to be the game-changer when it comes dealing with the rising burden of various life-threatening diseases such as cancer, diabetes, cardiovascular diseases along with others.

Diagnostic services in India: an untapped potential

With the second-largest population in the world, India also has a massive disease burden which has barred it from enjoying its demographic dividend optimally.

Digitization Improves Lab Supply Chain Management

Time is a major obstacle for the invention of a new product or for the development of a novel product from basic concepts. The time taken for an idea to be proved, prototyped and developed into beneficial invention determines the success of the product as there are multiple competitors existing in the market. As a result, scientists have to manage their time efficiently while executing their projects. However, unfortunately a lot of time is wasted when the required lab supplies such as reagents, kits, consumables, equipment etc. are not available while conducting crucial research experiments. Scientists often struggle in contacting the right biosuppliers, establishing trust with a new brand of product or facing delays in the delivery of an urgent material.

India Announces Major Tax Cuts To Boost Investment

USV Private Limited, an Indian multinational pharmaceutical, and biotechnology company based in Mumbai reacting quickly to the developments and leveraging on the government’s surprise corporate tax rate cut on September 20 announced that it will proceed with its investment of Rs 400 crore on a new state-of-art formulation plant at Vadodara in Gujarat.

'We Have Developed Over 15000 NCEs This Year'

A leading global Contract Research and Manufacturing Services (CRAMS) company in the area of drug discovery and development, TCG Lifesciences Pvt. Limited started its operations in 2001 in Kolkata and currently has a presence in the United States, Europe, and Japan.

'PPPs, CoEs Are Needed To Practice Precision Diabetes Care'

Roche Diabetes Care India, a pioneer in the development of diabetes management systems and services, has appointed executive from Novo Nordisk, Omar Sherief Mohammad as the new General Manager for its India business.

'India's Life Science And Healthcare Industries Are Some Of The Fastest Growing Sectors'

Promega Biotech India Private Ltd, a 100 per cent subsidiary of Promega Corporation USA started its operation in August 2014 in New Delhi has completed five years.

NDHB - Ambitious But Challenging

The vision of National Digital Health Blueprint (NDHB) is to create a National Digital Health Eco-system that supports Universal Health Coverage in an efficient, accessible, inclusive, affordable, timely and safe manner, through provision of a wide-range of data, information and infrastructure services, duly leveraging open, interoperable, standards-based digital systems, and ensuring the security, confidentiality and privacy of health-related personal information. Although it appears to be a very ambitious project, a large number of obstacles need to be tackled for its successful implementation.

'FICCI Heal 2019 - Health Of Healthcare In India'

“No public-private demarcation for the agenda of improving healthcare in India”

Industrial Enzymes Market Growing At 7% Touches Rs 2360 Crore

The market for enzymes in India was relatively small compared to other sectors but it is picking up as compared to other markets in the world.

Micronclean Targets Sales Growth For Cleanroom Consumables In India With Biospan Contamination Control Services

In 2017 Micronclean partnered with Biospan to sell its Cleanroom Consumables into the rapidly expanding Indian Pharmaceutical Cleanroom Market. Together they formed a joint venture company Biospan Contamination Control Services so that customers in India could benefit from a product range that has been sold into over 30 countries in the last 5 years.

Shortage In Europe Of Oncology Drugs... An Opportunity For Indian Pharma?

Indian drug companies are facing strong headwinds due to prompt regulatory action of United States Food and Drug Administration (USFDA), likely imposition of Border Adjustment Tax (BAT) and delay in new drug approvals. Probably, it is the best time for Indian pharma companies to  explore opportunities and business in the European market.

US FDA Warning Letters And Indian Pharma

Greater emphasis on quality will allow India to participate more fully in existing global venues such as the International Council for Harmonisation (ICH) and the Pharmaceutical Inspection Cooperation Scheme (PIC/S) – which will enable stronger collaboration and synergies among regulators. Quality is good for economic development, the market, and most importantly, patients and consumers everywhere.

Industry Needs To Work Closely With Indian Govt For Smooth Implementation Of GST

The new tax regime will contribute significantly towards every sector of economic growth, broad export expansion and without saying ample job opportunities. GST is collaborative approach and much awaited tax reform and it is a one more welcome step to move ahead towards more globalization. The roll out will yield many positive benefits but Companies will need to make major changes in their process.

People News

Veteran Biologist And Activist Passes Away.

Scientists Took To Streets For Robust Funds

Thousands of scientists, students, educational NGOs and science enthusiasts across the country came out on the streets on August 9th demanding robust funding for scientific research and policies to encourage a scientific temper among the population.

​“In India Till Now, Bioresearch Is Considered To Be A Bit Costly”

Dr Ashes Ganguly, founder Director of Cryogen Instruments India, one of the leading suppliers of Speciality/Isotopic Gases and Nuclear Medicines in the country, is heading the Indian Analytical Instrument Association (IAIA) as president since 2015 till 2018. In an interaction with BioSpectrum he shares his views as President of IAIA on government’s Make in India scheme and GST etc. Experts of the interview.

“Devise Simple Health Insurance Products To Enhance Coverage”

FICCI HEALTH INSURANCE CONFERENCE 2017

Batavia Joins International Consortium For Polio Eradication

Netherlands based Batavia Biosciences is joining an international consortium to develop and manufacture a safer type of polio vaccine.

Versatility Is Key To Success

Being the President and Chief of Science & Innovation at Metropolis Healthcare Ltd., India’s only multinational chain of pathology centre that provides the largest service menus in India offering more than 4,500 varieties of tests, Dr Nilesh Shah has been an inspirational figure.

Accurate Diagnosis, Efficient Disease Management: Modern Age of Pathology

The world of pathology labs has grown by leaps and bounds in the past decade.

The Policy Is A Game Changer

Recently, JP Nadda, Union Minister for Health and Family Affairs, released the National Health Policy (NHP) 2017. Patting the back of the minister, Prime Minister Narendra Modi described the policy as a ‘futuristic’ document which places the interests of the citizens foremost.

Policy Covers NCD Concerns

The National Health Policy 2017 covers various aspects like care for major non-communicable diseases (NCDs), geriatric healthcare, mental health, palliative care and rehabilitative care services.

The Generic Drug Push Needs Further Clarity

The policy encourages indigenous production of APIs and Key Starting Materials (KSMs) in several ways. However, a more thorough approach is required to once again enable the domestic API industry to become competitive. The Indian government needs to focus on developing the local chemical industry which can then in turn support API manufacturing.

Aims At Providing A Longer Term Stable Policy Environment

To overcome the challenges like Declining CAGR; Non-adherence to quality standards and norms; Growing competition from other countries; Dependence on imports for the key starting materials as also of the APIs; Lack of R&D and discovery of new molecules, and to improve the situation of the pharma industry, India has come up with draft pharma policy 2017.

Amgen Collaborates With Humana To Improve Health Outcomes

US Biotechnology company, Amgen and leading health organization, Humana have teamed up to identify opportunities to improve health outcomes and improve efficiency by unlocking new insights from the real world health care experiences of Humana's 13 million members.

Rich Agricultural Base To Boost State's Biotech Sector

Punjab, one of the prominent agricultural states of the country, is now shifting its gears from just being an agricultural state to biotechnology hub of North India.

Can State Make Biotech Park A Reality?

Governments worldwide have recognised biotech as a new age technology that is anticipated to play a significant role in improving the quality of life, at large.

“The Field Of Healthcare Is Changing Big Time Now”

“The Field Of Healthcare Is Changing Big Time Now”